https://preprod.pressherald.com/tag/vaccines/page/2

vaccines

Published
October 3, 2022

It’s flu vaccine time and seniors need revved-up shots

After flu hit historically low levels during the COVID-19 pandemic, it may be poised for a comeback.
Published
September 20, 2022

FDA releasing millions of Moderna boosters as states warn of shortages

Reconfigured shots are safe, but have been delayed amid inspection of an Indiana packaging plant last month.
Published
August 23, 2022

Your 1st brush with coronavirus could affect how a fall booster works

The version of a virus to which we're first exposed can dictate how we respond to later variants and, maybe, how well vaccines work.
Published
July 14, 2022

U.S. regulators clear way for more monkeypox vaccine shipments

State and local officials in the U.S. say the limited vaccine supplies aren’t keeping pace with the growing number of people seeking appointments, a gap that is fueling anxiety about the virus.
Published
June 15, 2022

FDA advisers move COVID-19 shots closer for kids younger than 5

The panel of outside experts vote unanimously that the benefits of Moderna’s shots outweigh any risks for children under 5 – that’s roughly 18 million youngsters.

advertisement

Published
June 10, 2022

FDA says Moderna vaccine for youngest children is safe and effective

The agency's outside advisers will meet next week to consider whether the Moderna vaccine and one by Pfizer and its German partner, BioNTech, should be authorized for infants and kids under 4 or 5.
Published
June 6, 2022

More traditional coronavirus shot could be available this summer

Novavax argues that its vaccine, which can stay stable at refrigerator temperatures long-term and may be better tolerated than alternatives, will have key advantages once the exigencies of the pandemic recede.
Published
May 23, 2022

Pfizer says 3 low-dose COVID shots protect children under 5

The 18 million children under 5 are the only group in the U.S. not yet eligible for COVID-19 vaccination.
Published
May 19, 2022

CDC advisers urge Pfizer booster for ages 5 to 11

Parents still are anxiously awaiting a chance to vaccinate kids under 5 – the only group not yet eligible in the U.S.
Published
March 29, 2022

If you got J&J vaccine, consider two mRNA booster shots, data suggest

A new study shows that 3 doses of a messenger RNA vaccine perform the best, while a Johnson & Johnson vaccine followed by a messenger RNA booster shot is next best.